Guidance for NHS staff about coronavirus treatments

For CMDUs

We created a tool, the Population Health Platform, to help COVID-19 Medicine Delivery Units (CMDUs) identify eligible patients for antiviral treatments.

CMDUs used this tool to:

• identify people who have received a positive COVID-19 test and who have at least one of the conditions deemed to be at the very highest risk of an adverse COVID outcome
• record which patients have been processed

This tool was developed to enable CMDUs to contact patients to arrange a triage assessment with a clinician.
It was not a decision support tool and there was no direction that clinicians must deliver treatment. Any decision to progress with treatment was after a clinical assessment and was based upon a clinician’s decision about their patient.

This system ran from the 16 December 2021 to 26 June 2023 and is now closed.

For the PANORAMIC study

Between 7 January 2022 and 30 June 2022, the Population Health Platform was also used to identify patients who may be eligible to access the treatments through the PANORAMIC study. This is a UK-wide clinical study sponsored by the University of Oxford and funded by the National Institute for Health Research.

Treatments are available for people aged 12 or over who have tested positive for COVID-19 and are at higher risk of becoming seriously ill.

For a person to qualify for treatment, a clinician must undertake a clinical assessment to ensure a patient is suitable. 

Learn more about the COVID-19 treatments policy and who can access the treatment.